<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Motif Bio plc

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Motif Bio plc

    Motif Bio is a clinical stage biopharmaceutical company developing novel antibiotics to treat patients with serious and life-threatening infections caused by multi-drug resistant bacteria. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Graham Lumsden
    • FOUNDED
      2003
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    SI-BONE, Inc.

    SI-BONE, Inc.

    SI-BONE is a medical device company that has pioneered a proprietary minimally inv...

    SI-BONE is a medical device company that has pi...

    Filing Type:    PU
    Anika Therapeutics Inc.

    Anika Therapeutics Inc.

    Headquartered in Bedford, Massachusetts, Anika Therapeutics, Inc. develops, manufa...

    Headquartered in Bedford, Massachusetts, Anika ...

    Filing Type:    PU
    Translate Bio, Inc.

    Translate Bio, Inc.

    Translate Bio is a leading mRNA therapeutics company developing a new class of pot...

    Translate Bio is a leading mRNA therapeutics co...

    Filing Type:    PU
    Catabasis Pharmaceuticals, Inc.

    Catabasis Pharmaceuticals, Inc.

    At Catabasis Pharmaceuticals, our mission is to bring hope and life-changing thera...

    At Catabasis Pharmaceuticals, our mission is to...

    Filing Type:    PU
    Seattle Genetics, Inc.

    Seattle Genetics, Inc.

    Founded 20 years ago, Seattle Genetics was built on a foundation of scientific inn...

    Founded 20 years ago, Seattle Genetics was buil...

    Filing Type:    PU
    WinSanTor, Inc.

    WinSanTor, Inc.

    WinSanTor’s mission is simple-develop a drug that works. We recognize that there...

    WinSanTor’s mission is simple-develop a drug ...

    Amount Raised:    $572,649.00
    Fundraising Status:    EC
    Filing Type:    CF
    Summit Therapeutics plc

    Summit Therapeutics plc

    Summit Therapeutics is a leader in antibiotic innovation. Our new mechanism antibi...

    Summit Therapeutics is a leader in antibiotic i...

    Filing Type:    PU
    Melinta Therapeutics, Inc.

    Melinta Therapeutics, Inc.

    Melinta Therapeutics, Inc. is dedicated to saving lives threatened by the global p...

    Melinta Therapeutics, Inc. is dedicated to savi...

    Filing Type:    PU
    Tetraphase Pharmaceuticals, Inc.

    Tetraphase Pharmaceuticals, Inc.

    Since the company’s inception, Tetraphase has developed a robust antibiotics pla...

    Since the company’s inception, Tetraphase has...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.